NCT00410748View on ClinicalTrials.gov

Safety and Tolerability of Long-Term Administration of Hydromorphone HCI CR (Controlled Release)

PHASE3CompletedINTERVENTIONAL

Enrollment

388

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 2000

Conditions

PainAnalgesics, Opioid

Interventions

DRUG

OROS hydromorphone HCI CR

All Listed Sponsors

lead

Alza Corporation, DE, USA

INDUSTRY

NCT00410748 - Safety and Tolerability of Long-Term Administration of Hydromorphone HCI CR (Controlled Release) | Biotech Hunter | Biotech Hunter